• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.

作者信息

Sellers T D, Campbell R W, Bashore T M, Gallagher J J

出版信息

Circulation. 1977 Jan;55(1):15-22. doi: 10.1161/01.cir.55.1.15.

DOI:10.1161/01.cir.55.1.15
PMID:830205
Abstract

Thirty-three patients with Wolff-Parkinson-White syndrome were studied electrophysiologically before and after administration of intravenous procainamide and oral quinidine sulfate. Procainamide prolonged the shortest R-R (SRR) interval between two consecutive pre-excited beats during atrial fibrillation 20-70 msec in 15 of 21 patients with no change observed in 6 of 21 patients. Quinidine sulfate prolonged the SRR 20-170 msec in all 16. In 14 of 18 patients where procainamide and quinidine were comparable, quinidine prolonged the SRR 30-100 msec more than procainamide.

摘要

相似文献

1
Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
Circulation. 1977 Jan;55(1):15-22. doi: 10.1161/01.cir.55.1.15.
2
Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.预激综合征心律失常的治疗
Chest. 1979 Jun;75(6):745. doi: 10.1378/chest.75.6.745a.
3
Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length.普鲁卡因胺和普罗帕酮终止预激综合征中的急性心房颤动:心房颤动周期长度的重要性
J Am Coll Cardiol. 1990 Nov;16(6):1408-14. doi: 10.1016/0735-1097(90)90384-2.
4
Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.
Ann Intern Med. 1976 Jan;84(1):44-5. doi: 10.7326/0003-4819-84-1-44.
5
Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.体内心房心肌峡部的传导:预激综合征的一种可能模型。
Circulation. 1987 Sep;76(3):637-47. doi: 10.1161/01.cir.76.3.637.
6
Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.预防性治疗散发性阵发性心房颤动的电生理药物测试:严重症状性预激患者的技术、应用及疗效
Am Heart J. 1982 Jun;103(6):941-9. doi: 10.1016/0002-8703(82)90555-5.
7
Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome.普鲁卡因酰胺、奎尼丁和阿义马林对预激综合征的作用。
Circulation. 1974 Jul;50(1):114-20. doi: 10.1161/01.cir.50.1.114.
8
Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.预激综合征中的快速性心律失常。治疗与预防。
JAMA. 1976 Mar 1;235(9):947-9.
9
[Electrophysiological properties of atrial fibrillation with WPW syndrome and the role of procainamide in conversion].预激综合征合并心房颤动的电生理特性及普鲁卡因胺在转复中的作用
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Apr;19(2):65-6, 123.
10
Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
Am Heart J. 1975 Jun;89(6):804-8. doi: 10.1016/0002-8703(75)90197-0.

引用本文的文献

1
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
3
Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.尼非卡兰治疗预激综合征伴心房颤动患者的疗效:电生理和临床研究结果。
J Am Heart Assoc. 2019 Jul 2;8(13):e012511. doi: 10.1161/JAHA.119.012511. Epub 2019 Jun 25.
4
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).执行摘要:欧洲心律协会室上性心律失常管理共识文件:得到心律学会(HRS)、亚太心律学会(APHRS)和拉丁美洲心脏刺激与电生理学会(SOLAECE)认可。
Arrhythm Electrophysiol Rev. 2016;5(3):210-224. doi: 10.15420/aer.2016:5.3.GL1.
5
Acute prolongation of myocardial refractoriness by sotalol.索他洛尔对心肌不应期的急性延长作用。
Br Heart J. 1982 Jun;47(6):521-6. doi: 10.1136/hrt.47.6.521.
6
Medical staff conference. Treatment of cardiac arrhythmias.医务人员会议。心律失常的治疗。
West J Med. 1979 Dec;131(6):533-43.
7
The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias.心电图在评估药物对心律失常的作用中的应用。
Br J Clin Pharmacol. 1978 Dec;6(6):473-85. doi: 10.1111/j.1365-2125.1978.tb00870.x.